intended to enhance stability, targeting, and cellular uptake of RNA payloads for research and drug development use cases. The organization works within the broader field of genetic medicine, applying synthetic biology and molecular engineering approaches to enable new therapeutic modalities. It also advances research programs targeting diseases such as oncology, autoimmune conditions, and other complex disorders through RNA-based interventions. ParcelBio collaborates with biotechnology and pharmaceutical partners to support development of next-generation RNA medicines and associated delivery technologies.